Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PpIX formation in curetted vs non-curetted skin after Metvix application
2016-005084-14Phase 4Terminated
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Dec 2016
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methyl aminolevulinate in actinic keratosis (AK), sponsored by Bispebjerg and Frederiksberg Hospital. Started Dec 2016; status: terminated.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2016-005084-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-005084-14.